-
Mashup Score: 0Ep.9 DAPA-TAVI English - 8 day(s) ago
“It is an honor to present on this podcast Dr. Sergio Raposeiras, lead author of the DAPA-TAVI trial.”
Source: www.youtube.comCategories: General Medicine NewsTweet
-
Mashup Score: 55
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors reduce hospitalizations related to heart failure (HF) in high-risk patients. To assess the efficacy
Source: www.jwatch.orgCategories: General Medicine News, General Journals & SocietTweet-
Trial of an SGLT-2 Inhibitor in Patients with Heart Failure and Valvular Disease Dapagliflozin was safe and reduced HF events soon after transcatheter aortic valve replacement in an older cohort, but it did not improve survival. https://t.co/hqGoB8HM1M @SheaHogan7 @NEJM #TAVR https://t.co/dVRXDW6ZYb
-
-
Mashup Score: 0SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients - 1 month(s) ago
Howard Herrmann, MD, MSCAI, Hospital of the University of Pennsylvania, and lead invesigator for the SMART trial, explains details on the 2-year data comparing the Evolut vs. Sapien 3 for TAVR in small annulus patients.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
VIDEO - Howard Herrmann, MD, MSCAI, Hospital of the University of Pennsylvania, and lead invesigator for the SMART trial, explains details on the 2-year data comparing the Evolut vs. Sapien 3 for TAVR in small annulus patients. #TAVR @MDT_StructHeart https://t.co/ZdgRfT2dOT
-
-
Mashup Score: 2
Acute coronary occlusion during transcatheter aortic valve implantation (TAVI) is an unwarranted complication associated with high mortality. The current TAVI practices recommend a multidetector comp…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
Must-read case report in the latest issue of CCI of left main coronary occlusion during #TAVR, cause by calcium embolization https://t.co/fnJJc64qtJ @ccijournal https://t.co/42Ruz6kNJg
-
-
Mashup Score: 2
Multiple studies over the years have linked PVL to an increased risk of adverse outcomes. New research out of Italy, however, suggests that device improvements made by Medtronic, Edwards Lifesciences and Boston Scientific may have reduced PVL’s influence.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
When using contemporary transcatheter ❤️ valves, PVL after #TAVR might not be as harmful as it was in the past, new research shows. https://t.co/pVpIa5RqRh
-
-
Mashup Score: 2
Multiple studies over the years have linked PVL to an increased risk of adverse outcomes. New research out of Italy, however, suggests that device improvements made by Medtronic, Edwards Lifesciences and Boston Scientific may have reduced PVL’s influence.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
When using contemporary transcatheter ❤️ valves, PVL after #TAVR might not be as harmful as it was in the past, new research shows. https://t.co/pVpIa5RqRh
-
-
Mashup Score: 3
Corresponding Author
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Do you agree with the Editorial by Thomas Modine, Lionel Leroux, and and Julien Ternacles just published in JACC: Cardiovascular Interventions, entitled 'Transcatheter Aortic Valve Replacement: On-Site Cardiac Surgery Still the Rule'? https://t.co/5a6aK5mos4 @JACCJournals #TAVR
-
-
Mashup Score: 0Radial secondary access during TAVR limits complications - 4 month(s) ago
Radial access is already the primary choice for many cardiologists performing PCI due to a lower risk of complications. The same appears to be true for secondary access during TAVR.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Radial secondary access limits complications during #TAVR @JACCjournals @ACCmediacenter https://t.co/sGrorNOsoP
-
-
Mashup Score: 3Treating AFib patients with TAVR still linked to elevated risks - 4 month(s) ago
While the technology and techniques associated with TAVR have advanced over the years, treating patients who present with baseline atrial fibrillation is still associated with certain risks.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Treating AFib patients with #TAVR still linked to elevated risks @SCC_CCS https://t.co/BQDJGHyV6B
-
-
Mashup Score: 15Readmissions after next-day discharge following transcatheter aortic valve implantation - 4 month(s) ago
Multicentre registry study evaluating the safety of next-day discharge after transcatheter aortic valve implantation with different transcatheter heart valves.
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
Great study led by @RodrigoBagur on next day discharge post #TAVR. In line with prior smaller studies including our own led by our former fellow Yasu Ichibori this study helps solidify the overall safety of this practice. @SakataYasushi https://t.co/kv3x3CM4G1
-
Ep.9 DAPA-TAVI enjoy and see until the final, surprise!!! #tavr https://t.co/Vk19XEqzYa